ID: ALA5281090

Max Phase: Preclinical

Molecular Formula: C20H23NSe

Molecular Weight: 356.37

Associated Items:

Representations

Canonical SMILES:  [Se]=C=NCCCCCCC1Cc2cccc3cccc(c23)C1

Standard InChI:  InChI=1S/C20H23NSe/c22-15-21-12-4-2-1-3-7-16-13-18-10-5-8-17-9-6-11-19(14-16)20(17)18/h5-6,8-11,16H,1-4,7,12-14H2

Standard InChI Key:  AUQAPKZQZHCYIW-UHFFFAOYSA-N

Associated Targets(non-human)

Leishmania major 2877 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Leishmania amazonensis 3813 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 356.37Molecular Weight (Monoisotopic): 357.0996AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Chuai H, Zhang SQ, Bai H, Li J, Wang Y, Sun J, Wen E, Zhang J, Xin M..  (2021)  Small molecule selenium-containing compounds: Recent development and therapeutic applications.,  223  [PMID:34217061] [10.1016/j.ejmech.2021.113621]

Source